← Leaderboards
Melanie Schorr Haines
Massachusetts General Hospital
$2,754,575
Attributed
$2,754,575
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $831.7K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,754,575 · 3
By mechanism
R01$1,410,166 · 1
K23$1,119,881 · 1
R03$224,528 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Miriam Antoinette Bredella$11,700,851
- Joy Tsai$945,749
- Lee S Cohen$6,077,186
- Jason David Roh$2,371,621
- Paloma Gonzalez-Perez$602,640
Others in their field
Other Emerging Leaders on “Muscle”
- Russell T Hepple · California Pacific Med Ctr Res Institute$13,797,603
- Manish Ishwar Shah · Baylor College Of Medicine$13,280,421
- Ian R Lanza · Mayo Clinic Rochester$11,741,175
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- James Even Voss · Scripps Research Institute, The$8,943,702
- Fritzie Isip Arce-McShane · University Of Chicago$8,435,878
Research focus
MuscleObesityAdultSarcopeniaMuscle FormAdult ObesityCardiometabolic RiskSkeletal MusclePrevalenceProspective StudiesRisk FactorsOverweightThinnessReduced Muscle MassPublic HealthMediatingFatty Acid Glycerol EstersImpairmentNon-Insulin-Dependent Diabetes MellitusRecruitAtherosclerosis Risk In CommunitiesEndocrine PhysiologyEnvironmentAppointment
Grant awards (11)
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity$690,694
R01 · FY2024 · DK · contact PI
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity$719,472
R01 · FY2023 · DK · contact PI
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.$112,264
R03 · FY2023 · DK · contact PI
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.$112,264
R03 · FY2022 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$198,335
K23 · FY2021 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$72,706
K23 · FY2021 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$198,335
K23 · FY2020 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$54,000
K23 · FY2020 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$198,335
K23 · FY2019 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$198,335
K23 · FY2018 · DK · contact PI
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity$199,835
K23 · FY2017 · DK · contact PI